Link Biologics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $3.66M

  • Investors
  • 3

Link Biologics General Information

Description

Developer of a protein biologic designed for people living with inflammatory and degenerative disorders. The company offers a combination of anti-inflammatory and tissue-protecting properties, enabling users with musculoskeletal and ophthalmological diseases to improve daily activities and quality of life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 124 City Road
  • London EC1V 2NX
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 124 City Road
  • London EC1V 2NX
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Link Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 23-Oct-2023 $3.66M Completed Pre-Clinical Trials
2. Accelerator/Incubator 01-Jan-2021 Completed Startup
1. University Spin-Out 01-Apr-2020 Completed Startup
To view Link Biologics’s complete valuation and funding history, request access »

Link Biologics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A Preferred
To view Link Biologics’s complete cap table history, request access »

Link Biologics Patents

Link Biologics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202416087-D0 Treatment of ocular disorders Pending 31-Oct-2024
WO-2026093560-A1 Treatment of ocular disorders Pending 31-Oct-2024
EP-4281098-A1 Use of link-tsg6 for the treatment of osteoarthritic pain Pending 20-Jan-2021
US-20250121028-A1 Use of link-tsg6 for the treatment of osteoarthritic pain Pending 20-Jan-2021
US-20150057229-A1 Method of treating bone disorders using tsg-6 Active 06-Mar-2006 A61K38/1709
To view Link Biologics’s complete patent history, request access »

Link Biologics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Link Biologics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Théa Open Innovation Venture Capital Minority
Creative Destruction Lab Accelerator/Incubator
The University of Manchester University Minority
To view Link Biologics’s complete investors history, request access »

Link Biologics FAQs

  • When was Link Biologics founded?

    Link Biologics was founded in 2020.

  • Where is Link Biologics headquartered?

    Link Biologics is headquartered in London, United Kingdom.

  • What is the size of Link Biologics?

    Link Biologics has 6 total employees.

  • What industry is Link Biologics in?

    Link Biologics’s primary industry is Drug Discovery.

  • Is Link Biologics a private or public company?

    Link Biologics is a Private company.

  • What is the current valuation of Link Biologics?

    The current valuation of Link Biologics is .

  • What is Link Biologics’s current revenue?

    The current revenue for Link Biologics is .

  • How much funding has Link Biologics raised over time?

    Link Biologics has raised $3.66M.

  • Who are Link Biologics’s investors?

    Théa Open Innovation, Creative Destruction Lab, and The University of Manchester have invested in Link Biologics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process